Many Investors Still Treating Gilead: 4 Launches This Year Could Prove Them Wrong
Gilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
Budgeting mistakes can quietly ramp up stress and debt. This intro highlights how small errors compound into financial strain and points to practical fixes you can start applying today.
19,441 articlesGilead sits at a crossroads: the HIV backbone remains strong, but a quartet of new launches could reshape the company...
A quick online search turned into a costly lesson when a creator clicked the first balance-check link for a Sephora g...
In a high-profile auction tied to Berkshire's annual meeting, a signed commemorative book changed hands for $50,000, ...
A dramatic rise in sandisk stock skyrocketed 857% in the first half of 2026 captured investors’ attention. This artic...
Missed Sandisk's 580% rally? No worry. You can still ride the AI-driven chip surge with three smart stock picks, clea...
A small-cap space stock can swing wildly, but patient, disciplined investors can map out potential outcomes. This gui...
PulteGroup accelerates its shift toward build-to-order homes to support margins as the 2026 housing market stays vola...
The monthly nonfarm payrolls report is a big market event, but it can mislead if you lean on it without guarding agai...
Data centers are growing fast, driven by cloud and AI. The real engine? Utilities expanding power capacity and reliab...
Oil stocks COP and Diamondback Energy offer very different risk-and-reward profiles. This guide breaks down cash flow...
The S&P 500’s top ten names now control a record share of the index, a dynamic that could ripple into Bitcoin and the...
As Elanco maps out its path for 2025, investors weigh growth drivers, margins, and catalysts. This guide breaks down ...